Overview


Dr. Rüdiger Herrmann focuses his practice on key transactions in the biotechnology and pharmaceutical sectors. He has a wealth of experience advising national and international clients on mergers and acquisitions, licensing agreements, initial public offerings, intellectual property matters and private equity/venture capital transactions. He has a particularly strong background in dealing with life science matters in the US, Europe, China and Taiwan.

Show More

Results


  • Advised Selvita on a global license agreement with an Italian pharma company*
  • Advised a German biotech company on a license and cooperation agreement with a world leading diagnostics company*
  • Advised Selvita on the launch of Nodthera Limited, a new biotech company launched by Epidarex Capital based on research by Selvita*

Show More

Recognition


  • Juve Handbook 2019, M&A Germany, Recommended
  • Chambers & Partners 2019, Life Sciences Germany, Band 3
  • Legal 500 EMEA 2019
  • Who’s Who Legal 2018, Life Sciences Germany, Recommended Expert

Show More

Community


  • Biotechnology Board Member, German Association for Pharmaceutical Industry e. V. (BPI)
  • Member of the Advisory Board of Impact Hub
  • German Association for Intellectual Property and Copyright Law

Show More

Credentials


Education
Higher Regional Court of Mainz, Second State Exam, 1995
University of Hagen, Dr. jur. (PhD), 1994
University of Mainz, First State Exam, 1992
Law, 1991

Admissions
Germany

Show More

Dr. Rüdiger Herrmann

Insights & Events / Media